Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results
The management said Sun Pharma witnessed a strong Q1, driven by a combination of robust core business growth, low base and some sale of Covid products Sun Pharmaceutical Industries Limited … Read More










